Literature DB >> 6849546

Mycobacterium simiae. Clinical features and follow-up of twenty-four patients.

R C Bell, J H Higuchi, W N Donovan, I Krasnow, W G Johanson.   

Abstract

The charts of twenty-four patients from whom Mycobacterium simiae was isolated from the sputum were reviewed and the patients seen in follow-up examination when possible. They were divided into 3 groups: 2 patients were felt to have had definite infection with M. simiae, 3 were felt to have had probable infection, and 19 showed no evidence of infection during follow-up for as long as 6 yr. All patients in the study had underlying pulmonary abnormalities. The results of PPD skin tests were negative in patients without evidence of tuberculosis. The patients without evidence of M. simiae infection were found to have had negative initial Acid Fast Bacillus smears, fewer sputum cultures positive for M. simiae, and lighter yields from cultures of M. simiae compared with those in the patients with M. simiae infection. We conclude that M. simiae is a nontuberculous mycobacterium capable of causing progressive granulomatous lung infection, but that it may also be identified as a causal isolate from the sputum of susceptible persons. Antituberculosis chemotherapy should not be employed in this latter group.

Entities:  

Mesh:

Year:  1983        PMID: 6849546     DOI: 10.1164/arrd.1983.127.1.35

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

Review 1.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

3.  A molecular epidemiological study of Mycobacterium simiae isolated from AIDS patients in Guadeloupe.

Authors:  E Legrand; A Devallois; L Horgen; N Rastogi
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.

Authors:  G Valero; F Moreno; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

5.  Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome.

Authors:  V Lévy-Frébault; B Pangon; A Buré; C Katlama; C Marche; H L David
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

6.  Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.

Authors:  Nathalie Coolen-Allou; Thomas Touron; Olivier Belmonte; Virgile Gazaille; Michel Andre; Jérôme Allyn; Sandrine Picot; Annabelle Payet; Nicolas Veziris
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

7.  Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients.

Authors:  M B Coyle; L C Carlson; C K Wallis; R B Leonard; V A Raisys; J O Kilburn; M Samadpour; E C Böttger
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

8.  Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis.

Authors:  C Maoz; D Shitrit; Z Samra; N Peled; L Kaufman; M R Kramer; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

Review 9.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

10.  Iatrogenic Mycobacterium simiae skin infection in an immunocompetent patient.

Authors:  Jaime Piquero; Vanesa Piquero Casals; Edgar Larotta Higuera; Mitchell Yakrus; David Sikes; Jacobus H de Waard
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.